Sign in to view content

Widefield Fluorescein Angiographic-Guided Aflibercept (WFFAGA) Monotherapy for Proliferative Diabetic Retinopathy (PDR)

Dennis M. Marcus, MD

Video
Published 2019

Dennis M. Marcus, MD

Diabetic Retinopathy Part I Symposium

Related

Continuous submicrogram fluocinolone acetonide (FAc) therapy for the treatment of diabetic retinopathy
Charles C Wykoff, MD, PhD, FASRS
Updates from the Field
2017
Impact of Intravitreal Anti-VEGF Therapy for Severe Non-Proliferative Diabetic Retinopathy (NPDR): Analyses Through a Monte-Carlo Simulation Model
Andrew A. Moshfeghi, MD, MBA, FASRS
On Demand Cases, Courses, and Papers
2021
Update on Systemic Therapies and Retinal and Choroidal Toxicity
Jaclyn L. Kovach, MD, FASRS
On Demand Cases, Courses, and Papers
2019

Category: Diabetic Retinopathy

See more